Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection.
about
Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-GTranscriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney DiseaseHLA-G Molecules in Autoimmune Diseases and InfectionsImmunomodulatory properties of HLA-G in infectious diseasesHuman leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 productionThe HLA-G 14 bp insertion/deletion polymorphism is a putative susceptible factor for active human cytomegalovirus infection in children.HLA-G gene repression is reversed by demethylationSoluble HLA-G expression and renal graft acceptance.Non-classical transcriptional regulation of HLA-G: an update.Immunohistochemical study of HLA-G expression in lung transplant recipients.Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditionsImplications of the polymorphism of HLA-G on its function, regulation, evolution and disease association.A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patientsChanges of inhibitory receptors on NK-92 cells and HLA-G on BeWo cells with Toxoplasma gondii infection.The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteinsHLA-G in transplantation: a relevant molecule for inhibition of graft rejection?Placental extravillous cytotrophoblasts persistently express class I major histocompatibility complex molecules after human cytomegalovirus infection.Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammationFunctions of HLA-G in the immune system.Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection.Emerging topics and new perspectives on HLA-G.HLA-G: a look back, a look forward.HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients.Soluble monomers, dimers and HLA-G-expressing extracellular vesicles: the three dimensions of structural complexity to use HLA-G as a clinical biomarker.The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology.HLA-G alleles and HLA-G 14 bp polymorphisms in a Brazilian population.The influence of cytomegalovirus on expression of HLA-G and its ligand KIR2DL4 by human peripheral blood leucocyte subsets.Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?Increased levels of soluble HLA-G molecules in Tunisian patients with chronic hepatitis B infection.Modulation of HLA-G expression in human neural cells after neurotropic viral infectionsHLA-G 14-bp Ins/Ins Genotype in Patients Harbouring Helicobacter pylori Infection: A Potential Risk Factor?Upregulation of Soluble HLA-G5 and HLA-G6 Isoforms in the Milder Histopathological Stages of Helicobacter pylori Infection: A Role for Subverting Immune Responses?HLA-G/C, miRNAs, and their role in HIV infection and replication.Human cytomegalovirus infection of M1 and M2 macrophages triggers inflammation and autologous T-cell proliferation.Elevation of human leukocyte antigen-G expression is associated with the severe encephalitis associated with neurogenic pulmonary edema caused by Enterovirus 71.HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus.HLA-G polymorphism and breast cancer.Liver HLA-G expression is associated with multiple clinical and histopathological forms of chronic hepatitis B virus infection.Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease.Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection.
P2860
Q24678795-2E9DC7FC-88D3-4A36-8582-EED3EE95056DQ26740125-2F19E0B2-1113-483B-A6D1-1D46350161B2Q26825516-1252D0F3-8378-4288-83BA-13E193554FC6Q27013645-2384518E-AD18-42D3-A5B6-DFD5E2A8BA9DQ28350682-DB692981-D59B-4331-8227-3DB0B9AFA83EQ33385464-F0644AAD-D1F0-4A4D-ADC9-732FF5AABB34Q33963997-7C46E6DD-9245-4DBB-87C0-5A4FC4BDDBBFQ33996904-3CF542B5-209C-4814-A6AD-E3C293EDF96AQ34017943-3A355E4E-46C4-4B16-8DDD-296496A4085CQ34018814-F29CF457-23DF-4F99-B78E-0D0BF10C4111Q34093041-0C36917A-F04E-4870-936E-295C3BDDAAD3Q34491478-7669315F-8DA5-4F51-A3DC-5B733075BE7BQ34714685-BE325A44-FE56-477C-B447-A197D5380A11Q34843334-4279C376-6C53-457C-BC9D-D56760A49F22Q34858638-E31D80A6-31CD-406B-9643-DB409B03406EQ35030797-9C2FD2F8-CDDF-4AF6-BFF9-8D32434AED74Q35155130-C2664A05-6E65-4298-8F09-64A109457733Q36179791-50A4F503-645F-46F7-BE6C-043844DD476AQ36795981-DD142F1C-EF38-4557-8195-C6C237D793ECQ37267886-0CFE5A5D-82A3-4FD5-A32F-4A1C6D682CF8Q37809764-73775C02-399C-4060-91D7-9EE64637123CQ37810814-3D1858FC-D09E-47FC-8A32-F117A5392450Q38789647-6ADE939E-8BB7-4FB8-A0AA-214A8CF5766CQ38839474-80291EF8-BB1E-4785-AC7F-86223628D11DQ38864796-9E06A235-3680-46DD-9FBA-30FD88C852A0Q39800387-5C40F451-9D8F-4DCB-A59B-429A8AC9BE05Q40090043-86514E0E-51EB-460C-ACA8-E736F94EFEA2Q40097257-9EC2AF7D-03F2-4F71-AF32-5E8AA79A03D1Q40233245-DBD9793C-D665-4D57-A2DC-4F412277AB95Q40669869-26FAB3D0-429B-40BF-B916-C09666888E71Q41001193-8C158786-EBED-4884-BD76-B4B67763ABACQ41011686-11388FD3-48CD-4113-86A9-A5BF58F54DD2Q42284873-F62C2F98-C6D7-4774-96F3-C223F0310D41Q42531590-9FE7767F-13F1-413E-9272-B11EF541C24DQ44663288-E3C825C8-8602-4751-8653-6C4B34AFE448Q45200038-91AC6FE4-A82F-43BB-80B9-9B3B57E539E4Q45261570-6B9F588E-522B-4977-B6D0-2211C918FF66Q45377958-A10E9D93-5A65-4A70-9CD1-793258389B50Q46362908-3B2DD12D-052F-4258-BFCE-39914DA35D83Q46722989-299C3CDD-9DCF-483E-97A5-48376CEC0B07
P2860
Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Modulation of HLA-G antigens e ...... man cytomegalovirus infection.
@en
type
label
Modulation of HLA-G antigens e ...... man cytomegalovirus infection.
@en
prefLabel
Modulation of HLA-G antigens e ...... man cytomegalovirus infection.
@en
P2093
P1476
Modulation of HLA-G antigens e ...... uman cytomegalovirus infection
@en
P2093
P304
P356
10.4049/JIMMUNOL.164.12.6426
P407
P577
2000-06-01T00:00:00Z